1.O'Grady, NP, Alexander, M, Burns, LA, et al. Summary of recommendations: guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011;52:1087–1099.
2.Bass, J, Halton, J, Drouet, Y, Ni, A, Barrowman, N. Central venous catheter database: an important issue in quality assurance. J Pediatr Surg 2011;46:942–945.
3.Beckers, MM, Ruven, HJ, Seldenrijk, CA, Prins, MH, Biesma, DH. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer. Thromb Res 2010;125:318–321.
4.Touré, A, Vanhems, P, Lombard-Bohas, C, et al. Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors. Am J Infect Control 2012;40:935–939.
5.Wolosker, N, Yazbek, G, Nishinari, K, et al. Totally implantable venous catheters for chemotherapy: experience in 500 patients. Sao Paulo Med J 2004;4:147–151.
6.Penel, N, Neu, JC, Clisant, S, Hoppe, H, Devos, P, Yazdanpanah, Y. Risk factors for early catheter-related infections. Cancer 2007;110:1586–1592.
7.Yoshida, J, Ishimaru, T, Kikuchi, T, Matsubara, N, Asano, I. Association between risk of bloodstream infection and duration of use of totally implantable access ports and central lines: a 24-month study. Am J Infect Control 2011;7:e39–e43.
8.Chang, YF, Lo, AC, Tsai, CH, et al. Higher complication risk of totally implantable venous access port systems in patients with advanced cancer: a single institution retrospective analysis. Pal-Hat Med 2013;27:185–191.
9.Ramritu, P, Halton, K, Cook, D, Whitby, M, Graves, N. Catheter-related bloodstream infections in intensive care units: a systematic review with meta-analysis. J Adv Nurs 2008;62:3–21.
10.Harron, K, Ramachandra, G, Mok, Q, Gilbert, R; CATCH Team. Consistency between guidelines and reported practice for reducing the risk of catheter-related infection in British paediatric intensive care units. Intensive Care Med 2011;37:1641–1647.
11.Mermel, LA, Allon, M, Bouza, E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1–45.
12.Sotir, MJ, Lewis, C, Bisher, EW, Ray, SM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol 1999;20:187–191.
13.Tomlinson, D, Mermel, LA, Ethier, MC, Matlow, A, Gillmeister, B, Sung, L. Defining bloodstream infections related to central venous catheters in patients with cancer: a systematic review. Clin Infect Dis 2011;53:697–710.
14.Hsieh, CC, Weng, HH, Huang, WS, et al. Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol 2009;15:4709–4714.
15.Crisinel, M, Mahy, S, Ortega-Debalon, P, et al. Incidence, prevalence and risk factors for a first infectious complication on a totally implantable venous-access port. Med Mai Infect 2009;39: 252–258.
16.Nam, SH, Kim, DY, Kim, SC, Kim, IK. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer 2010;54:546–551.
17.Freifeld, AG, Bow, EJ, Sepkowitz, KA, et al. Clinical practice guideline for the use of antimicrobial microorganisms in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52:e56–e93.
18.Nouwen, JL, Wielenga, JJ, van Overhagen, H, et al. Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol 1999;17:1304–1311.
20.Petrosillo, N, Drapeau, CM, Nicastri, E, et al. Surgical site infections in Italian hospitals: a prospective multicenter study. BMC Infect Dis 2008;8:34.
21.Pegues, D, Axelrod, P, McClarren, C, et al. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol 1992;49:156–162.
22.Adler, A, Yaniv, I, Steinberg, R, et al. Infectious complications of implantable ports and Hickman catheters in paediatric hae-matology-oncology patients. J Hosp Infect 2006;62:358–365.
23.Dasic, D, Hanna, SJ, Bojanic, S, Kerr, RS. External ventricular drain infection: the effect of a strict protocol on infection rates and a review of the literature. Br J Neurosurg 2006;5:296–300.
24.Schneeberger, PM, Smits, MH, Zick, RE, Wille, JC. Surveillance as a starting point to reduce surgical-site infection rates in elective orthopaedic surgery. J Hosp Infect 2002;51:179–184.
25.Delgado-Rodríguez, M, Gómez-Ortega, A, Sillero-Arenas, M, Martínez-Gallego, G, Medina-Cuadros, M, Llorca, J. Efficacy of surveillance in nosocomial infection control in a surgical service. Am J Infect Control 2001;29:289–294.
26.Berenholtz, SM, Pronovost, PJ, Lipsett, PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med 2004;32:2014–2020.